Turn Therapeutics Inc. Earnings Per Share (Basic)
Turn Therapeutics Inc. (TTRX) reported Earnings Per Share (Basic) of -$0.20 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Turn Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.20.
- Turn Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.03.
- Turn Therapeutics Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.01.
- Turn Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- Turn Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$0.12.
- Turn Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$0.07.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.20 10-Q · filed 2026-08-12 | -$0.23 10-Q · filed 2026-08-12 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.03 10-Q · filed 2026-05-11 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.12 10-K · filed 2026-03-31 |
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-13 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.13 10-Q · filed 2025-11-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.05 10-Q · filed 2026-08-12 | -$0.06 10-Q · filed 2026-08-12 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.01 10-Q · filed 2026-05-11 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-05-11 | |
| 2024-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.07 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$0.03 10-Q · filed 2025-11-13 | -$0.05 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |